California R&D Tax Credit

California R&D Tax Credit

Funds California innovators with tax credits for qualifying innovation expense and business development activity.

Eligibility · United States · US-CA

The California Research Credit (Form FTB 3523) is a state income tax credit available to California taxpayers — corporations and pass-through entities — that incur qualified research expenses (QREs) from research activities conducted within California. The credit is structured in close parallel to the federal research credit under IRC §41, with California-specific modifications. The standard rate is 15% of QREs exceeding a calculated base amount, plus 24% of basic research payments made to qualifying entities. For tax years beginning on or after January 1, 2025, California has conformed to the federal Alternative Simplified Credit (ASC) method, offering a credit equal to 3% of QREs exceeding 50% of average QREs for the three preceding years, or 1.3% of current-year QREs if no QREs existed in any of the three prior years. The prior Alternative Incremental Credit was repealed effective January 1, 2025.

There is no application process, competitive scoring, or deadline: the California Research Credit is an entitlement credit claimed directly on the taxpayer's California corporate or personal income tax return using Form FTB 3523. Any unused credit carries forward without limit until fully utilized. The credit applies only to QREs attributable to activities physically performed in California, making California-based R&D operations a prerequisite. Eligible taxpayers span the full range of for-profit California operating entities — from seed-stage hardware and biotech startups to large-scale manufacturers — as the credit is sector-agnostic and scales with R&D expenditure volume.

The most effective strategy for maximizing the California Research Credit is robust documentation of California QREs — wages, contractor costs, and supply costs tied to qualifying research activities — using contemporaneous records that clearly segregate R&D from non-R&D work. Taxpayers new to the credit should evaluate whether to elect the ASC method (generally simpler to compute and favorable for companies with growing R&D spend) on a timely filed original return, as the election is binding for that year. Unused credit from prior years carries forward and can produce material cash-equivalent value in future profitable years.